Find your path to Iqbal
240 people in our graph share verified history with Iqbal — schools, employers, funds. One of them is your warm intro.
About
Iqbal Mufti is an Operating Partner at SR One's London office, working on company creation, later-stage investments, and portfolio companies' industry engagement and partnering strategy. He previously worked at Hoffmann-La Roche, where he co-led the rare blood disorders portfolio strategy team and served as global Lifecycle Leader for Hemlibra (emicizumab). His background covers pharmaceutical product and portfolio strategy, late-stage development, global commercialization, business development, and M&A. He holds a BSc in Biotechnology from University College London and an MBA from Duke University's Fuqua School of Business.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- SR One Capital ManagementVenture Partnercurrent2022 — presentLondon, England, United Kingdom / Basel, Switzerland
- Windward BioBoard Membercurrent2025 — presentBasel, Basel, Switzerland
- Econic BiosciencesBoard Membercurrent2025 — presentLondon, England, United Kingdom
- Antag TherapeuticsBoard Observercurrent2024 — presentCopenhagen, Denmark
- CORXEL PharmaceuticalsBoard Observercurrent2026 — presentNew York, New York, United States
- Vibrant Biomedicines, Inc.Board Member2024 — 2025Boston, Massachusetts, United States
- RocheCo-Lead Disease Area Strategy Team - Rare Blood Disorders Franchise2020 — 2022Basel, Switzerland
- RocheLifecycle Leader - Haemophilia (Hemlibra)2019 — 2022Basel, Basel, Switzerland
- RocheIntegrated Strategy Leader - Haemophilia (Hemlibra)2018 — 2019Basel, Basel, Switzerland
- RocheCommercial Director (Global Commercial Head - Hemlibra)2018Basel, Basel, Switzerland
- RocheInternational Business Leader - Haemophilia2016 — 2018Basel, Basel, Switzerland
- RocheBusiness Unit Head - Sales & Marketing2015 — 2016Egypt
- Roche / GenentechGlobal Head Strategic Partnering - Ad Interim2014South San Francisco
- Roche / GenentechGlobal Business Development Director - Strategic Partnering2011 — 2014South San Francisco
- Hoffmann-La RocheGlobal Business Development Director, Strategic Partnering2010 — 2011New Jersey
- Hoffmann-La RocheGlobal Business Development Manager - Commercial Assessment2008 — 2010
- Roche PharmaceuticalsDirector - Commercial Operations2004 — 2007
Skills & more
From Iqbal's professional profile.
Colleagues at SR One Capital Management
Frequently asked questions
- Who is Iqbal Mufti?
- Iqbal Mufti is an Operating Partner at SR One's London office, working on company creation, later-stage investments, and portfolio companies' industry engagement and partnering strategy. He previously worked at Hoffmann-La Roche, where he co-led the rare blood disorders portfolio strategy team and served as global Lifecycle Leader for Hemlibra (emicizumab). His background covers pharmaceutical product and portfolio strategy, late-stage development, global commercialization, business development, and M&A. He holds a BSc in Biotechnology from University College London and an MBA from Duke University's Fuqua School of Business.
- Where does Iqbal Mufti work?
- Iqbal Mufti is Operating Partner at SR One Capital Management.
- What does Iqbal Mufti invest in?
- Iqbal Mufti invests in Biotech.
- Where did Iqbal Mufti go to school?
- Iqbal Mufti studied at Duke University - The Fuqua School of Business (MBA); UCL (BSc Hons, Biotechnology).
Same school
Also attended Duke University - The Fuqua School of Business274
+ 268 more
Shared employers
Also worked at Windward Bio1
Also worked at Antag Therapeutics10
+ 4 more











































